URL | https://www.manufacturingdive.com/news/samsung-bio |
Source | Manufacturing Dive |
Date Published | 09/15/2025 |
Author Name | Nathan Owens |
Company/Division name | Samsung Biologics |
Parent company | Samsung Biologics |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Year reshoring announced: | 2025 |
Capital investment ($): | 1,300 |
Country(ies) from which reshored: | Korea, South |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | Biopharmaceuticals |
What non-domestic negative factors made offshoring less attractive? | Tariffs, Total cost |